Improving Assessment, Treatment, and Understanding of Pregnant Women With Opioid Use Disorder: The Importance of Life Context

References

• Ait-Daoud, N., Blevins, D., Khanna, S., Sharma, S., & Holstege, C. P. (2017). Women and addiction. The Psychiatric Clinics of North America, 40(2), 285–297. https://doi.org/10.1016/j.psc.2017.01.005
   PubMed Web of Science ®Google Scholar
• Alexander, K. (2013). Social determinants of methadone in pregnancy: Violence, social capital, and mental health. Issues in Mental Health Nursing, 34(10), 747–751. https://doi.org/10.3109/01612840.2013.813996
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists [ACOG] (2017). Opioid use disorder in pregnancy - Actionable strategies to improve management & outcomes in New York State. American College of Obstetricians and Gynecologists.
   Google Scholar
• American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Author.
   Google Scholar
• American Psychological Association (2018). Resolution on pregnant and postpartum adolescent girls and women with substance-related disorders. http://www.apa.org/about/policy/pregnant-postpartum.aspx.
   Google Scholar
• Arnaudo, C. L., Andraka-Christou, B., & Allgood, K. (2017). Psychiatric co-morbidities in pregnant women with opioid use disorders: Prevalence, impact, and implications for treatment. Current Addiction Reports, 4(1), 1–13. https://doi.org/10.1007/s40429-017-0132-4
   PubMedGoogle Scholar
• Auerbach, M., Lobel, M., & Cannella, D. (2014). Psychosocial correlates of health-promoting and health-impairing behaviors in pregnancy. Journal of Psychosomatic Obstetrics and Gynaecology, 35(3), 76–83. https://doi.org/10.3109/0167482X.2014.943179
   PubMed Web of Science ®Google Scholar
• Brogly, S. B., Saia, K. A., Walley, A. Y., Du, H. M., & Sebastiani, P. (2014). Prenatal buprenorphine versus methadone exposure and neonatal outcomes: Systematic review and meta-analysis. American Journal of Epidemiology, 180(7), 673–686. https://doi.org/10.1093/aje/kwu190
   PubMed Web of Science ®Google Scholar
• Carroll, J., Reid, A., Biringer, A., Midmer, D., Glazier, R., Wilson, L., Permaul, J. A., Pugh, P., Chalmers, B., Seddon, F., & Stewart, D. (2005). Effectiveness of the antenatal psychosocial health assessment (ALPHA) form in detecting psychosocial concerns: A randomized controlled trial. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne, 173(3), 253–259. https://doi.org/10.1503/cmaj.1040610
   PubMed Web of Science ®Google Scholar
• Chandler, A., Whittaker, A., Cunningham-Burley, S., Williams, N., McGorm, K., & Mathews, G. (2013). Substance, structure and stigma: Parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods. The International Journal on Drug Policy, 24(6), e35–e42. https://doi.org/10.1016/j.drugpo.2013.04.004
   PubMedGoogle Scholar
• Coker, J. L., Catlin, D., Ray-Griffith, S., Knight, B., & Stowe, Z. N. (2018). Buprenorphine medication-assisted treatment during pregnancy: An exploratory factor analysis associated with adherence. Drug and Alcohol Dependence, 192, 146–149. https://doi.org/10.1016/j.drugalcdep.2018.07.042
   PubMed Web of Science ®Google Scholar
• Connell, T., Barnett, B., & Waters, D. (2018). Barriers to antenatal psychosocial assessment and depression screening in private hospital settings. Women and Birth : Journal of the Australian College of Midwives, 31(4), 292–298. https://doi.org/10.1016/j.wombi.2017.09.021
   PubMed Web of Science ®Google Scholar
• Crandall, C., Crosby, R. D., & Carlson, G. A. (2004). Does pregnancy affect outcome of methadone maintenance treatment? Journal of Substance Abuse Treatment, 26(4), 295–303. https://doi.org/10.1016/j.jsat.2004.02.001
   PubMed Web of Science ®Google Scholar
• Davie-Gray, A., Moor, S., Spencer, C., & Woodward, L. J. (2013). Psychosocial characteristics and poly-drug use of pregnant women enrolled in methadone maintenance treatment. Neurotoxicology and Teratology, 38, 46–52. https://doi.org/10.1016/j.ntt.2013.04.006
   PubMed Web of Science ®Google Scholar
• Ecker, J., Abuhamad, A., Hill, W., Bailit, J., Bateman, B. T., Berghella, V., Blake-Lamb, T., Guille, C., Landau, R., & Minkoff, H. (2019). Substance use disorders in pregnancy: Clinical, ethical, and research imperatives of the opioid epidemic [A report of a joint workshop of the society for maternal-fetal medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine]. American Journal of Obstetrics & Gynecology, 221(1), B5–B28. https://doi.org/10.1016/j.ajog.2019.03.022
   Google Scholar
• El-Mohandes, A., Herman, A. A., Nabil El-Khorazaty, M., Katta, P. S., White, D., & Grylack, L. (2003). Prenatal care reduces the impact of illicit drug use on perinatal outcomes. Journal of Perinatology: Official Journal of the California Perinatal Association, 23(5), 354–360. https://doi.org/10.1038/sj.jp.7210933
   PubMedGoogle Scholar
• Falletta, L., Hamilton, K., Fischbein, R., Aultman, J., Kinney, B., & Kenne, D. (2018). Perceptions of child protective services among pregnant or recently pregnant, opioid-using women in substance abuse treatment. Child Abuse & Neglect, 79, 125–135. https://doi.org/10.1016/j.chiabu.2018.01.026
   PubMed Web of Science ®Google Scholar
• Fine, A., & Kotelchuck, M. (2010). Rethinking MCH: The life course model as an organizing framework. US Department of Health and Human Services, Health Resources and Services Administration, Maternal and Child Health Bureau.
   Google Scholar
• Gemmill, A., Kiang, M. V., & Alexander, M. J. (2019). Trends in pregnancy-associated mortality involving opioids in the United States, 2007–2016. American Journal of Obstetrics and Gynecology, 220(1), 115–116. https://doi.org/10.1016/j.ajog.2018.09.028
   PubMed Web of Science ®Google Scholar
• Haight, S. C., Ko, J. Y., Tong, V. T., Bohm, M. K., & Callaghan, W. M. (2018). Opioid use disorder documented at delivery hospitalization - United States, 1999–2014. MMWR. Morbidity and Mortality Weekly Report, 67(31), 845–849. https://doi.org/10.15585/mmwr.mm6731a1
   PubMed Web of Science ®Google Scholar
• Hand, D. J., Short, V. L., & Abatemarco, D. J. (2017). Treatments for opioid use disorder among pregnant and reproductive-aged women. Fertility and Sterility, 108(2), 222–227. https://doi.org/10.1016/j.fertnstert.2017.06.011
   PubMed Web of Science ®Google Scholar
• Harrison, P. A., & Sidebottom, A. C. (2008). Systematic prenatal screening for psychosocial risks. Journal of Health Care for the Poor and Underserved, 19(1), 258–276. https://doi.org/10.1353/hpu.2008.0003
   PubMed Web of Science ®Google Scholar
• Haug, N. A., Duffy, M., & McCaul, M. E. (2014). Substance abuse treatment services for pregnant women. Obstetrics and Gynecology Clinics of North America, 41(2), 267–296. https://doi.org/10.1016/j.ogc.2014.03.001
   PubMed Web of Science ®Google Scholar
• Hensley, L., Sulo, S., Kozmic, S., & Parilla, B. V. (2018). Opioid addiction in pregnancy: Does depression negatively impact adherence with prenatal care? Journal of Addiction Medicine, 12(1), 61–64. https://doi.org/10.1097/ADM.0000000000000364
   PubMed Web of Science ®Google Scholar
• Hoeppner, B. B., Kelly, J. F., Urbanoski, K. A., & Slaymaker, V. (2011). Comparative utility of a single-item versus multiple-item measure of self-efficacy in predicting relapse among young adults. Journal of Substance Abuse Treatment, 41(3), 305–312. https://doi.org/10.1016/j.jsat.2011.04.005
   PubMed Web of Science ®Google Scholar
• Jaremko, K. M., Sterling, R. C., & Van Bockstaele, E. J. (2015). Psychological and physiological stress negatively impacts early engagement and retention of opioid-dependent individuals on methadone maintenance. Journal of Substance Abuse Treatment, 48(1), 117–127. https://doi.org/10.1016/j.jsat.2014.08.006
   PubMed Web of Science ®Google Scholar
• Johnson, E. (2019). Models of care for opioid dependent pregnant women. Seminars in Perinatology, 43(3), 132–140. https://doi.org/10.1053/j.semperi.2019.01.002
   PubMed Web of Science ®Google Scholar
• Jones, H. E., Deppen, K., Hudak, M. L., Leffert, L., McClelland, C., Sahin, L., Starer, J., Terplan, M., Thorp, J. M., Jr, Walsh, J., & Creanga, A. A. (2014). Clinical care for opioid-using pregnant and postpartum women: The role of obstetric providers. American Journal of Obstetrics and Gynecology, 210(4), 302–310. https://doi.org/10.1016/j.ajog.2013.10.010
   PubMed Web of Science ®Google Scholar
• Kotelchuck, M., Cheng, E. R., Belanoff, C., Cabral, H. J., Babakhanlou-Chase, H., Derrington, T. M., Diop, H., Evans, S. R., & Bernstein, J. (2017). The prevalence and impact of substance use disorder and treatment on maternal obstetric experiences and birth outcomes among singleton deliveries in Massachusetts. Maternal and Child Health Journal, 21(4), 893–902. https://doi.org/10.1007/s10995-016-2190-y
   PubMed Web of Science ®Google Scholar
• Krans, E. E., Bobby, S., England, M., Gedekoh, R. H., Chang, J. C., Maguire, B., Genday, P., & English, D. H. (2018). The Pregnancy Recovery Center: A women-centered treatment program for pregnant and postpartum women with opioid use disorder. Addictive Behaviors, 86, 124–129. https://doi.org/10.1016/j.addbeh.2018.05.016
   PubMed Web of Science ®Google Scholar
• Krans, E. E., Bogen, D., Richardson, G., Park, S. Y., Dunn, S. L., & Day, N. (2016). Factors associated with buprenorphine versus methadone use in pregnancy. Substance Abuse, 37(4), 550–557. https://doi.org/10.1080/08897077.2016.1146649
   PubMed Web of Science ®Google Scholar
• Kumar, N., Stowe, Z. N., Han, X., & Mancino, M. J. (2016). Impact of early childhood trauma on retention and phase advancement in an outpatient buprenorphine treatment program. The American Journal on Addictions, 25(7), 542–548. https://doi.org/10.1111/ajad.12437
   PubMed Web of Science ®Google Scholar
• Lander, L. R., Gurka, K. K., Marshalek, P. J., Riffon, M., & Sullivan, C. R. (2015). A comparison of pregnancy-only versus mixed-gender group therapy among pregnant women with opioid use disorder. Social Work Research, 39(4), 235–244. https://doi.org/10.1093/swr/svv029
   Web of Science ®Google Scholar
• Lobel, M., & Dunkel-Schetter, C. (2016). Pregnancy and prenatal stress. In H. S. Friedman (Ed.), Encyclopedia of mental health (2nd ed., vol. 3, pp. 318–329). Academic Press.
   Google Scholar
• Martin, S., Beaumont, J. L., & Kupper, L. L. (2003). Substance use before and during pregnancy: Links to intimate partner violence. The American Journal of Drug and Alcohol Abuse, 29(3), 599–617. https://doi.org/10.1081/ADA-120023461
   PubMed Web of Science ®Google Scholar
• Martin, C. E., Longinaker, N., & Terplan, M. (2015). Recent trends in treatment admissions for prescription opioid abuse during pregnancy. Journal of Substance Abuse Treatment, 48(1), 37–42. https://doi.org/10.1016/j.jsat.2014.07.007
   PubMed Web of Science ®Google Scholar
• Martin, C. E., Terplan, M., O’Grady, K. E., & Jones, H. E. (2018). Pregnancy intention and opioid use disorder treatment retention in the MOTHER study. The American Journal on Addictions, 27(5), 372–374. https://doi.org/10.1111/ajad.12735
   Web of Science ®Google Scholar
• Mattocks, K. M., Clark, R., & Weinreb, L. (2017). Initiation and engagement with methadone treatment among pregnant and postpartum women. Women’s Health Issues: Official Publication of the Jacobs Institute of Women’s Health, 27(6), 646–651. https://doi.org/10.1016/j.whi.2017.05.002
   PubMed Web of Science ®Google Scholar
• McHugh, R. K., Fitzmaurice, G. M., Carroll, K. M., Griffin, M. L., Hill, K. P., Wasan, A. D., & Weiss, R. D. (2014). Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients. Drug and Alcohol Dependence, 145, 121–126. https://doi.org/10.1016/j.drugalcdep.2014.10.002
   PubMed Web of Science ®Google Scholar
• Metz, V. E., Brown, Q. L., Martins, S. S., & Palamar, J. J. (2018). Characteristics of drug use among pregnant women in the United States: Opioid and non-opioid illegal drug use. Drug and Alcohol Dependence, 183, 261–266. https://doi.org/10.1016/j.drugalcdep.2017.11.010
   PubMed Web of Science ®Google Scholar
• Meyer, J. P., Isaacs, K., El-Shahawy, O., Burlew, A. K., & Wechsberg, W. (2019). Research on women with substance use disorders: Reviewing progress and developing a research and implementation roadmap. Drug and Alcohol Dependence, 197, 158–163. https://doi.org/10.1016/j.drugalcdep.2019.01.017
   PubMed Web of Science ®Google Scholar
• Mitchell, M. M., Severtson, S. G., & Latimer, W. W. (2008). Pregnancy and race/ethnicity as predictors of motivation for drug treatment. The American Journal of Drug and Alcohol Abuse, 34(4), 397–404. https://doi.org/10.1080/00952990802082172
   PubMed Web of Science ®Google Scholar
• Morris, M., Seibold, C., & Webber, R. (2012). Drugs and having babies: An exploration of how a specialist clinic meets the needs of chemically dependent pregnant women. Midwifery, 28(2), 163–172. https://doi.org/10.1016/j.midw.2011.03.002
   PubMed Web of Science ®Google Scholar
• Murphy, J., Goodman, D., Johnson, M. C., & Terplan, M. (2018). The Comprehensive Addiction and Recovery Act: Opioid use disorder and midwifery practice. Obstetrics and Gynecology, 131(3), 542–544. https://doi.org/10.1097/AOG.0000000000002493
   PubMed Web of Science ®Google Scholar
• Quispel, C., Schneider, T. A., Bonsel, G. J., & Lambregtse-van den Berg, M. P. (2012). An innovative screen-and-advice model for psychopathology and psychosocial problems among urban pregnant women: An exploratory study. Journal of Psychosomatic Obstetrics & Gynecology, 33(1), 7–14. https://doi.org/10.3109/0167482X.2011.649814
   PubMed Web of Science ®Google Scholar
• Reddy, U. M., Davis, J. M., Ren, Z., & Greene, M. F. (2017). Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes [Executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation]. Obstetrics and Gynecology, 130(1), 10.
   PubMed Web of Science ®Google Scholar
• Roberts, S. C. M., & Pies, C. (2011). Complex calculations: How drug use during pregnancy becomes a barrier to prenatal care. Maternal and Child Health Journal, 15(3), 333–341. https://doi.org/10.1007/s10995-010-0594-7
   PubMed Web of Science ®Google Scholar
• Sanders, J. M. (2012). Use of mutual support to counteract the effects of socially constructed stigma: Gender and drug addiction. Journal of Groups in Addiction & Recovery, 7(2-4), 237–252. https://doi.org/10.1080/1556035X.2012.705705
   Google Scholar
• Schempf, A. H., & Strobino, D. M. (2008). Illicit drug use and adverse birth outcomes: Is it drugs or context? Journal of Urban Health, 85(6), 858–873. https://doi.org/10.1007/s11524-008-9315-6
   PubMed Web of Science ®Google Scholar
• Schempf, A. H., & Strobino, D. M. (2009). Drug use and limited prenatal care: An examination of responsible barriers. Journal of Obstetrics and Gynecology, 200(4), 412-e1–412-e10.
   Google Scholar
• Smith, M. V., Costello, D., & Yonkers, K. A. (2015). Clinical correlates of prescription opioid analgesic use in pregnancy. Maternal and Child Health Journal, 19(3), 548–556. https://doi.org/10.1007/s10995-014-1536-6
   PubMed Web of Science ®Google Scholar
• Smith, D. C., Davis, J. P., Mendoza, N., & Zhang, S. (2017). Predictive validity of single-item motivational measures for emerging adults in substance-use disorder treatment. Journal of the Society for Social Work and Research, 8(2), 259–277. https://doi.org/10.1086/692018
   Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration [SAMHSA]. (2018). Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants. [No. HHS Publication No. (SMA) 18-5054]. Author.
   Google Scholar
• Sun, A. (2004). Principles for practice with substance-abusing pregnant women: A framework based on the five social work intervention roles. Social Work, 49(3), 383–394. https://doi.org/10.1093/sw/49.3.383
   PubMed Web of Science ®Google Scholar
• Sutter, M. B., Gopman, S., & Leeman, L. (2017). Patient-centered care to address barriers for pregnant women with opioid dependence. Obstetrics and Gynecology Clinics of North America, 44(1), 95–107. https://doi.org/10.1016/j.ogc.2016.11.004
   PubMed Web of Science ®Google Scholar
• Timko, C., Schultz, N. R., Cucciare, M. A., Vittorio, L., & Garrison-Diehn, C. (2016). Retention in medication-assisted treatment for opiate dependence: A systematic review. Journal of Addictive Diseases, 35(1), 22–35. https://doi.org/10.1080/10550887.2016.1100960
   PubMed Web of Science ®Google Scholar
• Whiteman, V. E., Salemi, J. L., Mogos, M. F., Cain, M. A., Aliyu, M. H., & Salihu, H. M. (2014). Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States. Journal of Pregnancy, 2014, 906723. https://doi.org/10.1155/2014/906723
   PubMedGoogle Scholar
• Wilder, C., Lewis, D., & Winhusen, T. (2015). Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder. Drug and Alcohol Dependence, 149, 225–231. https://doi.org/10.1016/j.drugalcdep.2015.02.012
   PubMed Web of Science ®Google Scholar
• Zedler, B. K., Mann, A. L., Kim, M. M., Amick, H. R., Joyce, A. R., Murrelle, E. L., & Jones, H. E. (2016). Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: A systematic review and meta-analysis of safety in the mother, fetus, and child. Addiction (Abingdon, England), 111(12), 2115–2128. https://doi.org/10.1111/add.13462
   PubMed Web of Science ®Google Scholar